These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1136617)

  • 21. [Long term results of the regeneration procedure, a new method of drug therapy of progressive parodontolysis (so-called parodontosis)].
    Sacher T
    ZWR; 1973 Jan; 82(1):25-32 contd. PubMed ID: 4514640
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience in using an iodine chloride solution for treating parodontosis].
    Orlov IuP; Gerbert SG
    Stomatologiia (Mosk); 1980; 59(1):62. PubMed ID: 6929130
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hydroxyprolinuria during algodystrophies. Therapeutic conclusions].
    Eisinger J; Acquaviva PC; d' Omezon Y; Schiano A; Recordier AM
    Rev Rhum Mal Osteoartic; 1974 Jun; 41(6):455-8. PubMed ID: 4423986
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of thyrocalcitonin in combination with nerobolil in the treatment of mandibular osteoradionecrosis].
    Laptev PI
    Stomatologiia (Mosk); 1979; 58(4):40-2. PubMed ID: 290058
    [No Abstract]   [Full Text] [Related]  

  • 25. [Functional state of calcitonin-producing cells of the female rats' thyroid as a result of experimental osteopenia therapy by graduated support loading combined with oestrogens and calcitonin injection].
    Loginov VI
    Aviakosm Ekolog Med; 2005; 39(6):33-7. PubMed ID: 16536031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial.
    Bem R; Jirkovská A; Fejfarová V; Skibová J; Jude EB
    Diabetes Care; 2006 Jun; 29(6):1392-4. PubMed ID: 16732029
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study of eel calcitonin for relief of pain from metastatic bone lesions].
    Sasaki F; Uchino J; Hata Y; Sato Y; Konno T; Okuno T; Ohira S; Taguchi K; Fuzisawa J; Oku T
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):437-42. PubMed ID: 2003741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of coenzyme Q7 on periodontal diseases (pyorrhea alveolaris): follow-up studies and effects on clinical function tests].
    Horii M; Sasaki T; Shimada S; Takeuchi T; Takada S
    Shikai Tenbo; 1979; 53(1):173-82. PubMed ID: 295940
    [No Abstract]   [Full Text] [Related]  

  • 29. Systemic therapy of periodontal disease.
    Nikitina TV
    Quintessence Int Dent Dig; 1978 Oct; 9(10):69-72. PubMed ID: 296429
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic use of calcitonin].
    Wasylewski A
    Pol Tyg Lek; 1981 Jun; 36(26):979-82. PubMed ID: 7027212
    [No Abstract]   [Full Text] [Related]  

  • 31. [The remote results of stimulating therapy in the treatment of parodontosis].
    Balianskaia GZ
    Stomatologiia (Mosk); 1968; 47(2):6-8. PubMed ID: 5240421
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical applications of calcitonin.
    Can Med Assoc J; 1971 Aug; 105(3):238-9. PubMed ID: 5563336
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Therapeutic effect of porcine calcitonin in senile osteoporosis.
    Shiraki M; Oyama T; Uchiyama S; Ito H; Orimo H
    Calcif Tissue Res; 1974; 15(2):162. PubMed ID: 4858512
    [No Abstract]   [Full Text] [Related]  

  • 34. [Calcitonin treatment of condensing bone metastases].
    Arlet P; Duffaut M; Gaillemin C; Le Tallec Y
    Nouv Presse Med; 1977 Dec; 6(41):3864. PubMed ID: 593874
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of proteolytic inhibitors in treating parodontosis by electrophoresis].
    Efanov OI; Loginova VA; Krylov IuF
    Stomatologiia (Mosk); 1978; 57(3):17-20. PubMed ID: 351875
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxyproline metabolism in periodontosis.
    Kulikova VS; Nikitina TV
    Stomatologiia (Mosk); 1975; 54(2):16-8. PubMed ID: 1055478
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of a 20% sodium sulfacyl solution in the overall treatment of parodontosis].
    Livshits VN; Glasova VL
    Stomatologiia (Mosk); 1979; 58(5):70. PubMed ID: 292183
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical study of a synthetic calcitonin derivative (elcatonin) in patients with metastatic bone tumors].
    Okayasu T; Masuda T; Hashimoto M; Tanabe T
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2703-9. PubMed ID: 3631970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of a permanent magnetic field in treating parodontosis].
    Filipchik IS; Blitsman RF
    Stomatologiia (Mosk); 1980 Jun; 59(3):27-8. PubMed ID: 6930714
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of calcitonin tolerance after intramuscular or intranasal administration in treatment for postmenopausal osteoporosis].
    Horst-Sikorska W; Ruszkowska J; Kosowicz J
    Przegl Lek; 1996; 53(1):9-11. PubMed ID: 8711177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.